No insider purchases or sales are on record for Senti Biosciences Holdings, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $22.0K | $0 | $2.0M | $3.3M |
| OPERATING INCOME | $-68.8M | $-61.0M | $-92.7M | $-62.1M |
| NET INCOME | $-61.4M | $-52.8M | $-71.1M | $-58.2M |
| EPS (DILUTED) | -2.73 | -12.03 | -16.01 | -2.23 |
| OPERATING CASH FLOW | $-43.4M | $-41.4M | $-52.4M | $-34.9M |
| CASH | $16.4M | $48.3M | $35.9M | $57.6M |
No password to create and no card required. We store your email address and nothing else.